Clinical Trials on Advanced Refractory Solid Tumors
Total 6012 results
-
OncoMed Pharmaceuticals, Inc.CompletedRefractory Solid Tumors | Advanced Relapsed TumorsUnited States
-
Taivex Therapeutics CorporationActive, not recruitingAdvanced Refractory Solid TumorsTaiwan
-
Taivex Therapeutics CorporationCompletedAdvanced Refractory Solid TumorsTaiwan
-
Sunshine Lake Pharma Co., Ltd.CompletedAdvanced Refractory Solid TumorsChina
-
National OncoVentureChong Kun Dang PharmaceuticalUnknownAdvanced Refractory Solid TumorsKorea, Republic of
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
CStone PharmaceuticalsBayerCompletedAdvanced Refractory Solid TumorsAustralia
-
Taivex Therapeutics CorporationTerminatedAdvanced Refractory Solid TumorsTaiwan
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnMesothelin-positive Advanced Refractory Solid TumorsChina
-
Radboud University Medical CenterBayerCompletedAdvanced Solid Tumor | Refractory to Standard TherapiesNetherlands
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Monopteros Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory CancerUnited States
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
NKGen Biotech, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer | Pathologically Confirmed Cancer Refractory to Conventional TherapyUnited States
-
Spago Nanomedical ABRecruitingSolid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid TumorAustralia
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Cosmo Technologies LtdRecruitingAdvanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10United States
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
University of Colorado, DenverUniversity of KentuckyCompletedRefractory Solid Tumors | Relapsed Solid TumorsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRefractory Solid Tumors | Relapsed Solid TumorsChina
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
TCRx Therapeutics Co.LtdRecruitingRefractory Solid Tumors | Relapsed Solid Tumors | TCR-T CellsChina
-
Incyte Biosciences Japan GKCompletedAdvanced Solid Tumors | Metastatic Solid TumorsJapan
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
NKGen Biotech, Inc.Active, not recruitingMetastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer | Unresectable CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors, Neoplasms, Advanced SolidHungary
-
M.D. Anderson Cancer CenterRecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
M.D. Anderson Cancer CenterRecruitingRefractory Solid TumorsUnited States
-
PharmaEngineCompletedRefractory Solid TumorsTaiwan
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterWithdrawnRefractory Solid TumorsKorea, Republic of